Starten Sie Ihre Suche...


Durch die Nutzung unserer Webseite erklären Sie sich damit einverstanden, dass wir Cookies verwenden. Weitere Informationen
Publikationen
Ergebnisse pro Seite:  10

Roos, WP; Jost, E; Belohlavek, C et al.

Intrinsic Anticancer Drug Resistance of Malignant Melanoma Cells Is Abrogated by IFN-beta and Valproic Acid

CANCER RESEARCH. Bd. 71. H. 12. 2011 S. 4150-4160


Linz, B; Faust, D; Kaina, B et al.

Investigation of base excision repair in proliferating and arrested cultures of fibroblasts

NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY. Bd. 383. 2011 S. 97-97


Meise, R; Kaina, B; Christmann, M

Knockdown of Fra-1 sensitizes human glioblastoma cells to the anticancer drug nimustine (ACNU)

NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY. Bd. 383. 2011 S. 101-102


Olsen, BB; Fischer, U; Rasmussen, TL et al.

Lack of the catalytic subunit of DNA-dependent protein kinase (DNA-PKcs) is accompanied by increased CK2 alpha' levels

MOLECULAR AND CELLULAR BIOCHEMISTRY. Bd. 356. H. 1-2. 2011 S. 139-147


Helbig, L; Damrot, J; Hulsenbeck, J et al.

Late Activation of Stress-activated Protein Kinases/c-Jun N-terminal Kinases Triggered by Cisplatin-induced DNA Damage in Repair-defective Cells

JOURNAL OF BIOLOGICAL CHEMISTRY. Bd. 286. H. 15. 2011 S. 12991-13001


Huelsenbeck, SC; Huelsenbeck, J; Fritz, G

Lovastatin protects cardiomyoblasts from doxorubicin-induced cytotoxicity by antagonizing topoisomerase II cleavable complex formation

NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY. Bd. 383. 2011 S. 49-49


Nilsson, S; Huelsenbeck, J; Fritz, G

Mevalonate pathway inhibitors affect anticancer drug-induced cell death and DNA damage response of human sarcoma cells

CANCER LETTERS. Bd. 304. H. 1. 2011 S. 60-69


Christmann, M; Verbeek, B; Roos, WP et al.

O-6-Methylguanine-DNA methyltransferase (MGMT) in normal tissues and tumors: Enzyme activity, promoter methylation and immunohistochemistry

BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER. Bd. 1816. H. 2. 2011 S. 179-190



Fritz, G; Henninger, C; Huelsenbeck, J

Potential use of HMG-CoA reductase inhibitors (statins) as radioprotective agents

BRITISH MEDICAL BULLETIN. Bd. 97. H. 1. 2011 S. 17-26